chr14-64924121-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001386928.1(CHURC1):āc.170A>Gā(p.Tyr57Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00385 in 1,607,926 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0030 ( 4 hom., cov: 31)
Exomes š: 0.0039 ( 21 hom. )
Consequence
CHURC1
NM_001386928.1 missense
NM_001386928.1 missense
Scores
5
8
5
Clinical Significance
Conservation
PhyloP100: 8.05
Genes affected
CHURC1 (HGNC:20099): (churchill domain containing 1) Predicted to enable zinc ion binding activity. Predicted to be involved in positive regulation of transcription, DNA-templated. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012085617).
BP6
Variant 14-64924121-A-G is Benign according to our data. Variant chr14-64924121-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 782958.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHURC1 | NM_001386928.1 | c.170A>G | p.Tyr57Cys | missense_variant | 2/4 | ENST00000549115.7 | NP_001373857.1 | |
CHURC1-FNTB | NM_001202559.1 | c.251A>G | p.Tyr84Cys | missense_variant | 2/14 | NP_001189488.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHURC1 | ENST00000549115.7 | c.170A>G | p.Tyr57Cys | missense_variant | 2/4 | 1 | NM_001386928.1 | ENSP00000448050 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00302 AC: 460AN: 152214Hom.: 4 Cov.: 31
GnomAD3 genomes
AF:
AC:
460
AN:
152214
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00352 AC: 870AN: 247434Hom.: 4 AF XY: 0.00341 AC XY: 457AN XY: 133848
GnomAD3 exomes
AF:
AC:
870
AN:
247434
Hom.:
AF XY:
AC XY:
457
AN XY:
133848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00394 AC: 5729AN: 1455594Hom.: 21 Cov.: 30 AF XY: 0.00376 AC XY: 2722AN XY: 723988
GnomAD4 exome
AF:
AC:
5729
AN:
1455594
Hom.:
Cov.:
30
AF XY:
AC XY:
2722
AN XY:
723988
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00302 AC: 460AN: 152332Hom.: 4 Cov.: 31 AF XY: 0.00285 AC XY: 212AN XY: 74486
GnomAD4 genome
AF:
AC:
460
AN:
152332
Hom.:
Cov.:
31
AF XY:
AC XY:
212
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
28
ALSPAC
AF:
AC:
17
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
47
ExAC
AF:
AC:
486
Asia WGS
AF:
AC:
3
AN:
3476
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 19, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | CHURC1: BS2; CHURC1-FNTB: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;T;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D;D;D;D;N
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;.;D;.;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;D;.;.;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
0.12
.;.;.;.;B;.
Vest4
MVP
MPC
0.81
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at